August 30, 2023 08:02 PM EDT

Scoop: Metagenomi is preparing for an IPO this fall, in what could jumpstart a wave of public offerings

Kyle LaHucik

Senior Reporter

Gene-editing biotech Metagenomi is preparing to go public and is working with the investment bank JP Morgan on a potential listing this fall, according to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Scoop: Metagenomi is preparing for an IPO this fall, in what could jumpstart a wave of public offerings

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Scoop: Metageno­mi is prepar­ing for an IPO this fall, in what could jump­start a wave of pub­lic of­fer­ings

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Scoop: Metagenomi is preparing for an IPO this fall, in what could jumpstart a wave of public offerings